Shire gets injunction against Roche over hemophilia drug

ZURICH (Reuters) - Pharmaceutical group Shire said on Sunday it had obtained a preliminary injunction in a Hamburg court against rival Roche over its hemophilia drug emicizumab, alleging incomplete and misleading statements surrounding the treatment.